TITLE

KEEP TRYING

PUB. DATE

February 2010

SOURCE

Commonweal;2/26/2010, Vol. 137 Issue 4, p6

SOURCE TYPE

Periodical

DOC. TYPE

Opinion

ABSTRACT

The article focuses on the results of a long-term research which raised doubts about the theorized parity between induced pluripotent stem cells (iPS) and human embryonic stem cells (hES).

ACCESSION #

48218558

Tags: EMBRYONIC stem cell research;  STEM cells -- Research

 

Related Articles

• Scientists react to government indecision. Brown, Phyllida // Nature Medicine;Aug99, Vol. 5 Issue 8, p855 

  Discusses the government's delay in deciding whether to permit research into the therapeutic use of human embryonic stem cells in Great Britain. Creation of anti-science climate; Reaction of the researchers towards the delay.

• Japan okays stem cells. Saegusa, Asako // Nature Biotechnology;Mar2000, Vol. 18 Issue 3, p246 

  Reports on the approval given by the bioethics committee of Japan's Science and Technology Council for research involving the use of embryonic stem cells. Reason cited by the committee for granting approval to the research; Plans of the committee to draw up guidelines for embryonic stem cell...

• Court paints with broad brush, upends U.S. stem cell policy. Lefkowitz, Jay // Hill;9/16/2010, Vol. 17 Issue 100, p31 

  In this article the author focuses on the court ruling which emphasized the preclusion of an embryonic stem cell research project from receiving federal fundings by the Dickey-Wicker Amendment if one step of the project results in the destruction of an embryo in the U.S.

• A world of difference. Aldhous, Peter // Nature;12/20/2001-12/27/2001, Vol. 414 Issue 6866, p838 

  Focuses on human embryonic stem (ES) cells research. Support of Great Britain on ES-cell research; Significance of therapeutic cloning; Plans of Advanced Cell Technology (ACT).

• Opponents of stem-cell patent win restrictions. Abbott, Alison; Schmidt, Oliver // Nature;8/1/2002, Vol. 418 Issue 6897, p470 

  Reports on the restriction in the scope of patent covering technologies for purifying human and animal embryonic stem cells by the European Patent Office in 2002. Details of the patent coverage; Groups that filed objections to the patent; Claim against the methods involved in the patent; Basis...

• The Case for Stem Cell Research. Zack, Lauren // Teen Ink;Dec2010, Vol. 22 Issue 4, p19 

  An essay is presented on the delay of the progress of embryonic stem cell research for the treatment of various diseases due to debates regarding the use of human embryos in the research.

• Corrigendum: Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Osakada, Fumitaka; Ikeda, Hanako; Mandai, Michiko; Wataya, Takafumi; Watanabe, Kiichi; Yoshimura, Nagahisa; Akaike, Akiori; Sasai, Yoshiki; Takahashi, Masayo // Nature Biotechnology;Mar2008, Vol. 26 Issue 3, p352 

  A correction to the article "Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells" that was published in the February 3, 2008 issue is presented.

• Historic retinal stem cell trial.  // Optometry Today;9/30/2011, Vol. 51 Issue 19, p8 

  The article reports that Moorfield Eye Hospital in Great Britain will be the site of Europe's first embryonic stem cell trial.

• Therapeutic cloning OK. Grisham, Julie // Nature Biotechnology;May2000, Vol. 18 Issue 5, p475 

  Reports that London, England-based Nuffield Council on Bioethics has released a report stating that research on human embryonic stem cells for the treatment of disease should be allowed. Potential benefits offered by research on somatic cell nuclear transfer for derivation of stem cells or...

Read the Article